INTRODUCTION
Accepted: December 27, 1999 Purpose: Pentoxifylline (PF) has been used to enhance Pentoxifylline (PF) is a 3Ј,5Ј-nucleotidase phosphodi- 
matozoa and 139 control ICSI using fresh or frozen epididy-
The twofold purpose of this study was first, to tozoa is poor, and this finding concerning necrozoospermia is confirmed in all our microsurgical epididymal sperm aspiration (MESA) and testicular sperm extraction (TESE) programs using immotile sperm of poor vitality. The outcome of ICSI procedures using PF-treated spermatozoa was compared to the outcome of control ICSI procedures using fresh or spermatozoa.
MATERIALS AND METHODS
PF-ICSI should be performed on all mature oocytes. Twenty couples were included in this protocol. After pituitary desensitization using a gonadotrophin-releasProtocol 1: Effect of PF-Treatment on Sperm ing hormone agonist (Decapeptyl 3 mg, Ipsen/Biotech, Motility Paris, France), ovarian stimulation was performed using recombinant follicular stimulating hormone Ten fresh or frozen epididymal or testicular spermatozoa samples displaying 0% total motility were (Gonal-F, Serono, Boulogne, France or Puregon, Organon, St Denis, France). Follicles were transvagiincluded in this protocol. All samples displaying at least one motile sperm (even if very poor on-place nally aspirated 35 h after injection of 10,000 IU human chorionic gonadotropin (hCG) (Organon). Oocyte motility) were excluded. Percutaneous MESA was carried out using a fine needle. After centrifugation for decoronization was carried out using a 15 IU/ml hyaluronidase solution (Hyaluronidase, Choay, Gentilly, 25 min at 300 g on a monolayer 80% PureSperm solution (JCD-SA, Gauville, France), epididymal sperFrance) diluted in BM1. Fresh or frozen epididymal or testicular spermatomatozoa were washed twice in BM1 (Ellios BioMedia, Paris, France) and suspended in 200 l of the zoa were processed as described in protocol 1. After preparation, samples were observed on an inverted same medium. To obtain sufficient material, TESE was performed by surgery rather than the percutaneous microscope to confirm total lack of motility and 7.2 mM PF solution was added vol/vol. If an adequate route. For each patient, biopsies were performed on both testicles at several stages. Histological analysis number of spermatozoa was available, samples were washed by centrifugation for 10 min at 1800 g to was always performed. Biopsies were mechanically disaggregated during half an hour using sterile slides in remove PF. For the poorest samples, the centrifugation step was omitted so as to avoid loss of spermatozoa, Petri dishes containing BM1 medium. The supernatant was centrifuged for 25 min (300 g) on a two-layer and the following cleaning technique was used. Three 20 l droplets of polyvinylpyrrolidone (PVP) were PureSperm gradient (45%/90%) and washed twice in BM1.
deposited alongside the sperm PF preparation on the Petri dish and overlayed with prewarmed CO 2 -equiliVitality was assessed by Y-eosine supravital staining on 20 l aliquots. The remaining sperm suspension brated oil (Ovoil, JCD-SA, Gauville, France). Using an ICSI pipette, PF-treated spermatozoa were transferred was deposited on a Petri dish and motility was analyzed as in protocol 1. If total immotility was observed, the into the first PVP droplet and immobilized with the tip of the pipette. Immobilized spermatozoa were then preparation was mixed vol/vol with a 7.2 mM PF solution (Torental, Hoechst Houdé, Paris, France) aspirated into the pipette with a minimum of PF-containing medium and transferred to another part of the diluted in BM1 and reassessed for motility after 10-min incubation at room temperature. In cases of frozen PVP droplet containing no PF. Using a new pipette, immobilized spermatozoa in the first PVP droplet were spermatozoa, freezing was performed as follows. Epididymal or testicular spermatozoa preparations were aspirated with a minimum amount of PVP and transferred to the second droplet of fresh PVP. After stirring diluted vol/vol in Spermfreeze (JCD-SA, France). Spermatozoa were thawed at 37ЊC, centrifuged for 25 with the tip of the pipette to dilute the remaining PFcontaining medium, the spermatozoa were reaspirated min (300 g) on a monolayer 80% PureSperm solution, and washed twice. Sperm motility and vitality were into the pipette. After repeating this cleaning operation in the third PVP droplet, ICSI was performed as assessed using the same methods as for fresh sperm.
described by Van Steirteghem et al. (9) . In order to assess the effectiveness of PF-ICSI, Protocol 2: Selection of Motile Spermatozoa fertilization and cleavage rates, embryo quality, and for ICSI pregnancy and implantation rates were prospectively compared to those observed in control ICSI performed The use of PF was proposed to all our patients displaying 0% total motility in fresh or frozen epididyduring the same period. Control ICSI were always performed using fresh or frozen epididymal or testicumal or testicular spermatozoa. Because of the unsatisfactory results observed after ICSI using immotile lar spermatozoa, but injected spermatozoa were always spontaneously motile and never PF-treated. Embryo spermatozoa when sperm vitality is low (fertilization rate ϭ 15% in cases where vitality is Ͼ 40%), the quality was assessed using an embryo score based on the presence of anucleate fragments, blastomere Institutional Review Board at the Institut de Médecine de la Reproduction decided for ethical reasons that irregularities in shape and/or size, and cleavage stage (10). The embryo scores range from 0 to 4 points, 0-Protocol 2: Selection of Motile Spermatozoa for ICSI point embryos corresponding to uncleaved embryos and 4-point embryos corresponding to the best One hundred fifty-nine ICSI using epididymal embryos, i.e., embryos displaying no anucleate fragand testicular spermatozoa before or after freezing ments or no blastomere irregularities and which are at were performed, including 139 control ICSI using the 4-cell stage at the time of transfer 48 hr after spontaneously motile spermatozoa (87.4%) and 20 oocyte retrieval.
ICSI using PF-treated spermatozoa (12.6%). Sperm count was low in all PF-ICSI cases (range: 50-10 4 sperm in the whole preparation). The outcome of ICSI Statistical Analysis using PF-treated spermatozoa are summarized in Table  Statistical (Table  IV) . Six pregnancies occurred in the PF group, includProtocol 1: Effect of PF Treatment on ing one miscarriage, three ongoing pregnancies, and Spermatozoa Motility the birth of two girls (Table II; case No.2: one fetal loss during first trimester and one healthy birth; case Sperm motility before and after PF treatment in No. 6: one healthy birth). In two cases extra embryos the ten specimens displaying 0% sperm motility are were frozen and thawed, but no pregnancy occurred. shown in Table I . Stimulation of some sperm was observed in all cases. Almost half of the live sperm were stimulated (14.8% motile out of 29.2% live epi-DISCUSSION didymal sperm, and 13.6% out of 33.6% live testicular sperm).
Following the report of Yovich et al. (2), PF was widely used to enhance spermatozoa motility in IVF programs (4-6,11). Regarding ejaculated spermato- PF enhanced motility in two cases of cryopreserved mia has been confirmed in all MESA and TESE programs using spermatozoa of poor vitality. Nagy et al. ductal spermatozoa.
Random injection of immotile spermatozoa from (16), who obtained a 45% fertilization rate and a 28.6% pregnancy rate after ICSI using untreated immotile specimens of poor vitality consistently leads to disappointing results. Liu et al. (8) observed that the outtesticular spermatozoa, unfortunately did not specify sperm vitality in their study. As sperm vitality was come of ICSI using dead spermatozoa is poor, with intact cells remaining present in the ooplasm 20 hr only 32% in the present series, the fertilization rate (FR) without the use of PF probably would not have after injection. This finding concerning necrozoosperexceeded 16% (about 50% of oocytes injected with live spermatozoa after random sperm selection). Out- (17) obtained one birth of twin males after ICSI using PF-treated immotile testicular spermatozoa. The pregnancies and births presented in this article confirm the usefullness of this method on fresh ACKNOWLEDGMENTS testicular spermatozoa and to our knowledge are the first published successful PF-ICSI using epididymal
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The possibility of PF-induced embryotoxicity has Jean-Pierre Franquebalme, Eric Glowaczower, Gérard Ruf, Marie-Christine Sitri-Bouhaben, and Mariebeen reported. Tournaye et al. (18, 19) observed several adverse effects of PF on mouse embryos, but they Christine Thibaut-Labbé, for their clinical followup at the Institut de Médecine de la Reproduction, Mar- (20) later reported that these adverse effects could be prevented by washing spermatozoa after PF treatment.
seille, France. Lacham-Kaplan and Trouson (21) observed no adverse effects on embryo development, neither when cumulus-free oocytes were inseminated with spermatozoa REFERENCES for up to 18-20 hr in 3 mM PF nor when subzonal 
